Join Growin Stock Community!
Back to LLY.US Analysis
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

cash-and-debt-chart

LLY Cash & Debt

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

As of Q3'25, Eli Lilly (LLY) reported Cash & Short-term Investments of USD 9.91B and Debt of USD 42.51B. This marks a significant increase in both cash reserves and debt compared to previous quarters, with cash reaching its highest level in the observed period. From Q1'23 to Q3'25, the chart shows a generally upward trend in both Cash & Short-term Investments and Debt, with particularly sharp increases beginning in Q4'23. Debt levels have more than doubled from USD 18.88B in Q1'23 to USD 42.51B in Q3'25, while cash holdings, after fluctuating around USD 2.5B–3.5B, surged to USD 9.91B in Q3'25. This suggests aggressive capital raising or financing activities, possibly to support expansion or strategic investments.